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Abstract
AIM: The optimal treatment for bile duct stones (in terms of
cost, complications and accuracy) is unclear. The aim of our
study was to determine the predictive factors for preoperative
endoscopic retrograde cholangiopancreatography (ERCP).
METHODS: Patients undergoing preoperative ERCP ( 90 d
before laparoscopic cholecystectomy) were evaluated in
this retrospective study from the 1st of January 1996 to the
31st of December 2002. The indications for ERCP were elevated
serum bilirubin, elevated liver function tests (LFT), dilated
bile duct ( 8 mm) and/or stone at US examination, coexisting
acute pancreatitis and/or acute pancreatitis or jaundice in
patient’s history. Suspected prognostic factors and the
combination of factors were compared to the result of ERCP.
RESULTS: Two hundred and six preoperative ERCPs were
performed during the observed period. The rate of successful
cannulation for ERC was (97.1%). Bile duct stones were
detected in 81 patients (39.3%), and successfully removed
in 79 (97.5%). The number of prognostic factors correlated
with the presence of bile duct stones. The positive predictive
value for one prognostic factor was 1.2%, for two 43%,
for three 72.5%, for four or more 91.4%.
CONCLUSION: Based on our data preoperative ERCP is
highly recommended in patients with three or more positive
factors (high risk patients). In contrast, ERCP is not indicated
in patients with zero or one factor (low risk patients).
Preoperative ERCP should be offered to patients with two
positive factors (moderate risk patients), however the
practice should also be based on the local conditions (e.g.
skill of the endoscopist, other diagnostic tools).
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The rate of coexisting common bile duct stones (CBDS) in patients
undergoing cholecystectomy for cholelithiasis is approximately
7-20%[1-3]. The dramatic shift from conventional to laparoscopic
cholecystectomy (LC) in the last 15 years has opened a large
debate over the optimal management of patients with CBDS
undergoing cholecystectomy[4,5]. It is generally accepted that
bile duct stones should be removed (even if asymptomatic),
because they may be associated with severe complications
such as pancreatitis and cholangitis. The management of
coexisting CBDS may be surgical or endoscopic followed by
surgery. Gallbladder preservation has also been suggested,
however it has not become universal[6]. A group of surgeons
have recommended laparoscopic management of coexisting
CBDS by intraoperative cholangiography or intraoperative
ERCP and surgical removal of the stones[7-9]. However, manipulation
of the bile duct during LC is not popular among laparoscopic
surgeons. Recent studies suggest that it can be done safely
and does not prolong hospitalisation[10,11], but minimal
invasiveness and cost-effectivity remain questionable[12].
        ERCP is the most popular peri-LC bile duct imaging method.
It is readily available, safe, highly accurate and has therapeutic
potential, even in old patients[13]. Furthermore ERCP offers the
possibility to study bile duct anatomy, identify abnormalities of
the bile ducts as well as being useful in the differential diagnosis
of questionable lesions (e.g. malignancy). The role of new, less
invasive imaging techniques (e.g. endoscopic ultrasound - EUS,
magnetic resonance cholangiopancreatography - MRCP) is less
well characterized[14-16].
       Routine preoperative ERCP may not be recommended, due
to the low percentage of coexisting cholecysto-choledocholithiasis,
a large number of negative investigations, and a small but
significant risk of associated morbidity and high additional
costs. Postoperative ERCP could reduce the number of
unnecessary interventions and the majority of retained stones
and postoperative leakages can be treated, although a second
operation is required in case of failure. The development of
more reliable predictors of CBD stones, based on the patient’s
clinical, biochemical and ultrasound (US) presentations, could
allow a more appropriate use of preoperative ERCP (or EUS,
MRCP). However, there is still no consensus as to which
particular indicator, or set of indicators should be used, or as to
the threshold values of various indicators[3,17-22].
     The aim of this study was to determine a precise and easily
applicable clinical, biochemical and US (selection) criteria for
patients who should undergo further investigation (preoperative
ERCP) prior to LC/surgery.
MATERIALS AND METHODS
Patients who underwent preoperative ERCP from the 1st January
1996 to the 1st January 2003 ( 90 d before laparoscopic
cholecystectomy) were evaluated in this retrospective study.
       The indications for ERCP were one or more of the following:
elevated serum bilirubin ( 2× upper limit of normal - ULN)
concentration, elevated liver function tests [LFT, 1.5× ULN:
either aspartate-aminotransferase (AST), alanine-amino-
transferase (ALT), alkaline phosphatase (ALP) or γ-glutamyl
transpeptidase (GGT) activities], dilated bile duct ( 8 mm) and/or
stones at US examination, coexisting acute pancreatitis and/or
acute pancreatitis or jaundice in patient’s history. The predictive
values of age, sex and colic were also investigated. The majority
of the ERCPs were performed by two expert endoscopists.
Suspected prognostic factors and combination of factors were
compared to the results of the ERCP.
      Serum bilirubin concentration, AST, ALT, ALP and GGT
activities were measured by Olympus AU600 (Olympus Co.
Ltd, Shizuoka, Japan) autoanalyser at 37 . The enzyme
activities were expressed in U/L and serum bilirubin concentration
was given in µmol/L.
Statistical analysis
Sensitivity, specificity, positive and negative predictive values
were calculated for individual factors (compared to all other
cases) and for combination of factors. Student t-test with
separate variance estimates was performed to test the
demographic differences. χ2 test and Fisher exact test were
performed to compare between patients with a different number
of suggested factors. P<0.05 was considered statistically
significant. For the statistical analysis Statistica 6.1 (Statsoft
Inc, OK, USA) was used.
RESULTS
A total of 2985 ERCPs and 1248 LCs were performed in the
Csolnoky F. Province Hospital between 1st January 1996 and
the 31st December 2002. Using our selection criteria (a minimum
of one positive factor) preoperative ERCP was performed in
206 patients (16.5%, Table 1). Seventy-seven percent of the
patients were women and 23% men. The mean age of women
was significantly lower (P = 0.02, Table 2). The mean waiting
time between ERCP and LC was 17.3 d. Thirty-nine percent of
the patients were operated within 3 d, almost 60% within
one week.
Table 1  Number of ERCP and/or LC cases per year in the
Csolnoky Ferenc Hospital, Veszprém, Hungary
Year  ERCP LC ERCP-LC
1996    373   99     15
1997    393 164     28
1998    375 140     27
1999    490 189     33
2000    558 183     36
2001    378 246     42
2002    391 227     25
Total 2 258          1 248   206
Average          423/yr 178 29/yr
Table 2  Preoperative ERCP, age and gender of patients (n=206)
Gender    n (%) Mean age
Male   48 (23)      57.4
Female 158 (77)      51.0
Total 206 (100)      52.5
       A successful cannulation was done in 200 patients (97.1%,
Table 3). CBD stones were found in 81 patients (39.3%), the
stone/stones were removed endoscopically in 79 cases (97.5%).
There was a tendency of increased frequency of CBD stones
in men (24/48 = 50.0%) compared to women (57/158 = 36.1%,
P = 0.06 by Fisher exact test), but CBD stones were equally
common in elder ( 60 years) and younger (<60 years) patients
(50/128 = 39.1% vs 31/78 = 39.7%).
       The results for each individual criterion are shown in Tables
4, 5. With the exception of jaundice or pancreatitis in the patient’s
history the positive predictive value of each criterion was high
(58-72%). Sensitivity and specificity were compared to patients
lacking the specific factor.
Table 3  Results of preoperative ERCPs performed prior to LC
(n = 206)
ERCP finding  n   %
Common bile duct (CBD) stone   81 39.3
Negative 119 57.8
CBD not filled      6   2.9
Successful EST and duct clearance          79/81 97.5
Complication      3   1.5
-bleeding      1   0.5
-pancreatitis      1   0.5
-stone impaction      1   0.5
Table 4  Common bile duct stones in cases of different posi-
tive prognostic factors (PPF)
Factor           Number Stone Negative Unsuccessful  %
Hyperbilirubinaemia (>2)   61 44 16     1     72
Elevated ASAT/ALAT (>50%) 116 74 39     3     64
Elevated GGT/ALP (>50%) 134 79 52     3     59
Acute pancreatitis (AP)   26 18   7     1     69
AP in the anamnesis   20   4 16     0     20
Jaundice in the anamnesis   29   1 26     2       3
US: CBD 8 mm   53 38 14     1     71
US: bile duct stone     7   4   3     0     57
Biliary colic 106 62 42     2     58
Table 5  Total predictive value of different positive predictive
factors (PPF) for common bile duct stone
Factor    PPV %  NPV % Sensitivity %Specificity %
Hyperbilirubinaemia      73.3        73.6         54.3       86.6
Elevated ASAT/ALAT    65.4        91.9         91.3       67.2
Elevated GGT/ALP      60.3        97.1         97.5       56.3
Acute pancreatitis (AP)   72.0        73.5         22.2       96.2
AP in the anamnesis      20.0        57.2           4.9       86.5
Jaundice in the anamnesis    3.7        53.7           1.2       78.2
US: CBD 8 mm      73.1        70.9         46.9       88.2
US: bile duct stone      57.1        60.1           4.9       97.5
      A more realistic approach was to compare the predictive
value in association with other factors. Table 6 demonstrates
that the positive predictive value of the investigated factor
was high in cases with (at least) two concurrently positive
factors. The positive predictive value of two positive markers
was 41-55%, again with the exception of pancreatitis or jaundice
in the anamnesis.
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Table 6  Predictive value of positive predictive factors (PPF)
for CBD stones and effect of associated other factors, n (%)
Factor    Alone                One            Two or more
        further factor     further factors
Hyperbilirubinaemia    0/3                 1/5 (20) 43/53 (81)
Elevated ASAT/ALAT  1/11 (9) 13/32 (41) 60/73 (82)
Elevated GGT/ALP    1/24 (4) 16/35 (46) 62/75 (83)
Acute pancreatitis (AP)     -   0/3 18/23 (78)
AP in the anamnesis    1/12 (8)   0/3    3/5 (60)
Jaundice in the anamnesis 0/27   1/2 (50)        -
US: CBD 8 mm    0/7 6/11 (55) 32/35 (91)
US: bile duct stone    0/1        -     4/6 (67)
      The association between the number of positive factors
and the presence of CBD stones is shown in Tables 7, 8. One
factor alone was associated with a very low risk of CBD stone
(1.2%). In patients with two, three and four or more positive
factors, CBD stones were detected in 43.1%, 72.5% and 91.4%
respectively. If we omitted history of jaundice and pancreatitis
from the factors the corresponding data were 2.7% (1/41), 1.9%
(1/54), 45.6% (23/48) and 82.3% (56/69) for patients with zero,
one, two and three or more positive factors.
Table 7  Association between the number of positive predic-
tive factors and ERCP findings (n = 206)
   Number of       Number      Stone    Negative    Unsuccessful  %
positive factors
   1         84  1   80 3    1.2
   2         46 19   25 2  43.1
   3         40 29   11 0  72.5
4         36 32      3 1  91.4
P<0.00001 for the whole group, P<0.00001, between group 1
and groups 2, 3, 4, group 2 and group 4, P = 0.008, between
groups 2 and 3, P = 0.035, between groups 3 and 4.
Table 8  Predictive value of predictive factors according to the
number of positive factors
    Number of   Number       PPV      NPV   Sensitivity   Specificity
positive factors %         %    %             %
1       84             1.2   -       -  -
2       46           43.1       98.7   95.2            76.1
3       40           72.5       84.0   59.1            90.5
4       36           91.4       72.0   40.2            98.4
P<0.00001 for the whole group, P<0.00001, between group 1
and groups 2, 3, 4 and group 2 and group 4, P = 0.008, between
groups 2 and 3, P = 0.035, between groups 3 and 4.
DISCUSSION
Although laparoscopic cholecystectomy has become the
treatment of choice for cholelithiasis, the treatment of coexisting
cholecysto-choledocho-lithiasis is still controversial[1,3,8,10,15,17].
The surgical management of CBD stones requires a skilled
laparoscopic surgeon and the options of management include
conversion to open CBD exploration, intraoperative or
postoperative ERC. In contrast, no single non-invasive method
is sensitive and/or specific enough to predict the presence of
CBD stones. Individual findings are less important than the
overall clinical presentation.
      A number of methods have been used for the diagnosis of
CBDS, including new and improved radiological techniques.
However some of them are invasive, more expensive and require
special equipment. A major advantage of ERCP is that it could
also offer a therapeutic possibility. Approximately 90-95% of
CBDS could be managed endoscopically[1,23], but it is expensive,
technically demanding and is associated with small but significant
morbidity.
     The question is whether preoperative ERCP should be
routinely indicated or whether it should be kept for selected
cases only. Most of the studies concluded that routine
preoperative ERCP was not indicated[1,20,24]. One of the earliest
studies is the well-known study from Neuhaus et al.[24]. They
performed routine preoperative ERCP in 288 prospective
patients  prior to LC. The rate of successful cannulation was
91.7%, and normal anatomy was found in 86%. CBDS were proved
in 29 patients (11%), the stone was asymptomatic in 9 patients.
Endoscopic sphincterotomy was performed in all cases and the
stones were extracted in all but three patients. One additional
patient was operated due to complications. In concordance with
the reported rate of 6-13.2% in other studies[1,14,20], coexisting
cholecysto-choledocho-lithiasis was found in 6.5% of our LC
patients (81 cases by preoperative ERCP).
      The aim of this and previous studies was to determine a
precise and easily applicable selection of clinical, biochemical
and US criteria, which would enable the identification of patients
with low risk of CBD stones (without the necessity for invasive
procedures), and with higher risk of CBD stones who should
undergo further preoperative investigation. The selection of
patients was difficult. CBD stones were more common in
patients with symptoms (e.g. jaundice, cholangitis, pancreatitis)
and laboratory alterations including elevated serum bilirubin
and liver function test. However, 8-10% of gallstone patients
might have asymptomatic ductal stones[3,25,26].
      The positive predictive value of laboratory data for CBD
stones was found to be 60-87% in various studies[26,27]. In our
study it was 57.1-73.3% in univariate analysis. However in most
of the cases they were not individual parameters. In concordance
with previous studies we could not identify jaundice and
pancreatitis in the anamnesis as a predictor variable.
     Traditional abdominal US is a valuable diagnostic tool.
Although it is less sensitive (20-30%) in the detection of ductal
gallstones, it provides important additional information about
the degree of dilation of the bile ducts. The sensitivity of iv.
cholangiography is also relatively low, moreover, it is associated
with a severe risk of side effects. However, due to new non-
ionic radiocontrast agents and radiological techniques, more
and more research groups have started to routinely apply this
technique again with improving results[3]. Laparoscopic
intraoperative cholangiography is a useful and reliable method,
although its indication remains debated[10,28]. The sensitivity
of traditional CT is similar to that of US, but 3D helical techniques
could offer an accuracy comparable to that of MRCP[29]. MRCP
and endoscopic US could approach the diagnostic value of
ERCP[14,15,30].
      None of the aforementioned and analyzed factors is fit for
the prediction of bile duct stones with sufficient certainty by
itself. A combination of the prognostic factors is routinely
applied. Several authors have constructed complicated scoring
systems[16,23,27]. However, most of these systems require highly
specific and sophisticated softwares, and no universally
accepted system exists. More practical is the use of suggested
clinical scores based on routine clinical data (jaundice,
pancreatitis, liver function tests, ductal dilation and/or stones
in the choledochus on US) in everyday practice[17,20]. Some
authors also included the presence of small gallstones, old age
and gender.
      In concordance with our study, in the different studies based
on large patient populations, CBDS/ductal stones or other
pathologic deviations were found in 40-60% of ERCP cases
performed on selected/restricted indications[1,16,18,20]. Based on
the prognostic factors, patients were usually divided into low,
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medium and high-risk CBD stone groups.
       Peter Cotton[31] has presented his guidelines in the American
Journal of Surgery. In his opinion the main constituents of the
indications of preoperative ERCP were the following: positive
predictive factors for CBD stones, the expertise of the endoscopist,
and the pressure for laparoscopic intervention as opposed to
open surgery. In concordance with our suggestion, he identified
low, medium and high-risk patients for CBD stones based on
the anamnesis, liver function tests, and ductal dilation on US.
According to his conclusions, preoperative ERCP was not
indicated for low-risk patients, while it must absolutely be
performed in the high-risk group. As for the medium risk group,
seemingly paradoxically, preoperative ERCP was only indicated,
if the local endoscopist was mediocre. With an experienced
endoscopist, preoperative intervention should be avoided, ERCP
is to be performed only after the surgery, if the need arises.
      Rieger et al.[26] found CBD stones in 56 patients (53%) of
the 106 ERCP performed in combination with 1140 LC. More
than two-fold elevation in any liver function test, multiple
abnormal laboratory tests, stones in the biliary tract on US, a
more than 7 mm, dilated ductus choledochus were taken as
positive predicting factors for preoperative ERCP. The multi-
center study of Welbourn et al.[32] in England also aimed to
identify the exact indications of selective preoperative ERCP.
The retrospective analysis of 306 preoperative ERC and 1396
LC showed that the predictive value of jaundice was 75%, that
of pancreatitis 56%, while the predictive value of pathologic
US or liver function tests was 48 %. In a prospective study of Sarli
et al.[3], 74 symptom-free, CBD stone patient data were evaluated.
Positive US, biliary colic, elevated serum aminotransferase
and alkaline phosphatase levels and the presence of multiple,
smaller stones were associated with a higher risk, while acute
cholecystitis and non-specific upper gastrointestinal complaints
were associated with a lower risk. In our study jaundice, elevated
LFTs and dilated choledochus or stones in the bile duct on US
examination gave a similarly high positive predictive value in
univariate analysis for bile duct stones.
      In our opinion, the major shortcoming of the above studies
is that they analyzed the effects of different predictive factors
separately, which in accordance with our own findings, could
easily result in misleading conclusions. Santucci et al.[33] and
Geron et al.[7] came to the same conclusion, emphasizing the
importance of the co-existence of several pathologic markers at
the same time. Furthermore, the American Society for
Gastrointestinal Endoscopy (ASGE) in its guideline[29] favors
the establishment of the aforementioned risk categories based
on “simple clinical” data, such as clinical picture, laboratory
findings and US. Interestingly, it recommends intraoperative
(during the laparoscopic cholecystectomy) cholangiography
to be performed even in low-risk/negative patients, followed
by laparoscopic or endoscopic postoperative intervention, if
required. In the medium-risk group endosonography or MRCP
is recommended as the method of choice or, if these are not
available, ERCP. According to the guideline, ERCP should be
the first (therapeutic) intervention for high-risk patients.
      In Hungary, ERCP is performed on a relatively high level
and is generally available. Among the new imaging techniques,
the availability of MRCP and endosonography is still limited.
At the same time, due to financing reasons, ERCP turns out to
be more cost-effective. The accessibility of intraoperative
laparoscopic imaging techniques is also limited.
      In summary, based on the literature and our own results, the
following duideline can be established about the indications of
preoperative ERCP.
      The possibility of CBD stones should be considered after
the evaluation of clinical, laboratory and US findings. Zero or
one positive predictive factor indicates low risk, while the risk
is high if three or more factors are present. Two positive
predictive factors suggest medium risk. In the low risk group
preoperative ERCP is not recommended, LC is advisable without
restrictions. In the high risk group the indication of preoperative
ERCP is unambiguous. In the medium-risk population,
preoperative ERCP is generally indicated. If available, MRCP
can be a good alternative. In case of a highly qualified
endoscopist, ERCP should be postponed until the surgery can
be considered.
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